All Posts By

Ben Kemp

UK and India landmark trade deal abolishes medical device tariffs HighlightsHighlights Archive

UK and India landmark trade deal abolishes medical device tariffs

The UK and India have officially signed a long-awaited trade deal, bringing in almost £6 billion in new investment and set to create over 2,200 British jobs across the country. New analysis suggests the deal will increase UK GDP by £4.8 billion each year. The UK already imports £11 billion in goods from India, but liberalised tariffs on Indian goods…
Ben Kemp
July 29, 2025
Innovate UK Health & MedTech Global Mission to Singapore 2025 – applications now open Membership NewsMembership News Archive

Innovate UK Health & MedTech Global Mission to Singapore 2025 – applications now open

Innovate UK’s Global Business Innovation Programme consists of a ‘Get ready’ preparation phase, 5-day innovation visit to Singapore focused on Health & Medical Technologies, an ‘Exploit the opportunity’ workshop and support from an Innovate UK innovation and growth specialist. All phases of the programme are aimed at helping your business maximise the opportunities identified and develop innovation projects with partners…
Ben Kemp
July 29, 2025
CTDA (Coronavirus Test Device Approvals) Update Membership NewsMembership News ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

CTDA (Coronavirus Test Device Approvals) Update

The MHRA recently announced that the current CTDA (Coronavirus Test Device Approvals) process for approval of SARS-CoV-2 tests is intended to be repealed with the introduction of the pre-market statutory instrument. Once Parliament agrees the statutory instrument, the MHRA have confirmed that the CTDA regulations will no longer apply from when the statutory instrument is made into legislation. They anticipate this…
Ben Kemp
July 29, 2025
BIVDA response to articles concerning the UK’s private diagnostic testing market Membership NewsMembership News Archive

BIVDA response to articles concerning the UK’s private diagnostic testing market

Members will have seen articles from outlets including the BBC last week regarding the UK's private diagnostic testing market. BIVDA wishes to respond to these items. In Vitro Diagnostics are a key part of any health system. Before being placed on the market, tests are reviewed by the Medicines and Healthcare products Regulatory Agency (MHRA) to ensure they are safe…
Ben Kemp
July 29, 2025
APPG for Life Sciences meeting on clinical trials in the NHS Membership NewsMembership News Archive

APPG for Life Sciences meeting on clinical trials in the NHS

The APPG for Life Sciences, of which BIVDA forms part of the secretariat, held our third event of the year in Parliament. The session explored how clinical trials are delivered within the NHS, examining both the challenges and opportunities in the current system and considering ways the process could be improved. BIVDA Board Member and CEO of Glyconics and Symbiotic.blue…
Ben Kemp
July 23, 2025
Media Monitoring: 17th – 23rd July HighlightsHighlights Archive

Media Monitoring: 17th – 23rd July

  Breakthrough Blood Test Detects Cancer Early and Forecasts Treatment Success In a recent publication, a research team from Cambridge and Proteotype Diagnostics unveiled a blood test that detects cancer early and predicts treatment response by decoding immune system signals rather than relying on tumour DNA. Published in a seminal paper titled "Immunodiagnostic plasma amino acid residue biomarkers detect cancer…
Ben Kemp
July 22, 2025
UKHSA labs at Porton Down and Colindale to merge and be based in Harlow HighlightsHighlights Archive

UKHSA labs at Porton Down and Colindale to merge and be based in Harlow

The government is investing billions of pounds into a national biosecurity centre (NBC) in Harlow, Essex, set to be the largest of its kind in Europe. This aims to ensure the UK is better prepared for future pandemics and emerging biosecurity risks. The project will be given including £250 million over this Parliament to bring vital research and testing, currently…
Ben Kemp
July 22, 2025
Global aid cuts to accelerate AMR deaths and economic impact by 2050 HighlightsHighlights Archive

Global aid cuts to accelerate AMR deaths and economic impact by 2050

Drug-resistant infections could claim millions more lives and severely damage the global economy by 2050, according to new modelling. The study, funded by the UK government and conducted by the Center for Global Development, warns that antimicrobial resistance (AMR) could reduce global GDP by $1.7 trillion annually if no action is taken. Major economies such as the US, UK, and…
Ben Kemp
July 22, 2025
Register for CPI’s Innovation in MedTech and Diagnostics Conference 2025: Connecting the Ecosystem Membership NewsMembership News Archive

Register for CPI’s Innovation in MedTech and Diagnostics Conference 2025: Connecting the Ecosystem

BIVDA members CPI are holding their two-day MedTech and Diagnostics Conference 2025: Connecting the Ecosystem on Tuesday 21 October 2025 at 09:00. The conference will explore the future of diagnostics and healthcare delivery in the UK, spotlighting the nation’s strengths in NHS clinical excellence, innovative R&D, and advanced wound care. The agenda features keynote presentations on the next decade of…
Ben Kemp
July 22, 2025
Ipsos polling shows public support for NHS 10-Year Plan reforms HighlightsHighlights Archive

Ipsos polling shows public support for NHS 10-Year Plan reforms

New polling from Ipsos reveals a generally positive public response to the government’s 10 Year Health Plan. According to the survey, 35% of people believe the plan will improve outcomes for patients, while only 9% think it will make things worse. Reform UK voters were the only group with a higher proportion (17%) believing the plan would have a negative…
Ben Kemp
July 22, 2025